Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scar Formation and Quality of Life after Debrase vs Standard of Care
2011-001889-17Phase 3Completed
- Sponsor
- MediWound
- Start
- May 2011
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of collagenase clostridium histolyticum in burn scar and Skin and connective tissue disease (2 arms), sponsored by MediWound. Primary endpoint: Primary: Long-term scar assessment using Modified Vancouver Scar Scale. Started May 2011; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
burn scarSkin and connective tissue disease
Beyond the preview
Go deeper on 2011-001889-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001889-17.